Description
This product utilizes Engineered Tregs that have been engineered with our proprietary GeneCircuit technology to specifically target CD70 (clone 2E7JB3). We employs the HBV (CMV-Cy2-IL-17-BamHI) vector components and the SynExpress system of the Introns Knockout/Delayed feedback for a robust and sustained response against cancers.
Host
Human
Target
CD70
Clone
2E7JB3
Species Reactivity
Human
Cell Source
Engineered Tregs
Sensor Gene
Cy2
Promoter
CMV
Effector Gene
IL-17
Insertion Sites
BamHI
Gene Modification
Knockout
Modification Domain
Introns
Carrier Type
HBV
Transformation Accuracy
0.98
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.